Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex-specific differences in psoriasis in the Czech Republic

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F21%3A10422538" target="_blank" >RIV/00669806:_____/21:10422538 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11120/21:43921105 RIV/00216208:11140/21:10422538 RIV/00216208:11110/21:10422538 RIV/00098892:_____/21:N0000095 and 3 more

Result on the web

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ai.Jxrgyyd" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ai.Jxrgyyd</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/dth.14849" target="_blank" >10.1111/dth.14849</a>

Result language

angličtina

Original language name

Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex-specific differences in psoriasis in the Czech Republic

Original language description

BIOREP is a Czech registry of patients with psoriasis undergoing biological treatment. The objective of the study was to compare differences in demographic data, previous therapy, comorbidities, severity of psoriasis, quality of life, drug survival rates, and reasons for discontinuation between men and women. We analyzed a cohort of patients from the registry treated between May 2005 and January 2020. The total study population of 2,472 patients (4,051 treatment series) included 913 females and 1,559 males. Women were significantly older than men at the onset of the biological treatment (47.8 vs. 45.4 years, p &lt; 0.0012) and the mean durations of psoriasis and that from its diagnosis until initiation of biological therapy, were longer in women (29.6 vs. 27.2 years and 23.2 vs. 20.6 years, p &lt; 0.0012). Women as compared with men were also more often diagnosed with psoriatic arthritis (43.5% vs. 33.0%, p &lt; 0.0012). The prevalence rate of comorbidities was equivalent for both sexes except for that of depression (11.4% females vs. 3.7% males, p &lt; 0.0012). Both the DLQI and PASI scores were significantly different at baseline (DLQI = 16.0 and PASI = 19.5 for men vs. DLQI 17.6 = and PASI = 17.7 for women, p &lt; 0.0012). The survival probability with biological therapy was significantly lower in women for both biologically naïve and non-naïve patients, and there was more evidence of adverse effects in women. Our research demonstrates significant differences relative to multiple factors associated with psoriasis between men and women.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30216 - Dermatology and venereal diseases

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Dermatologic Therapy

ISSN

1396-0296

e-ISSN

—

Volume of the periodical

34

Issue of the periodical within the volume

2

Country of publishing house

US - UNITED STATES

Number of pages

10

Pages from-to

e14849

UT code for WoS article

000617942300001

EID of the result in the Scopus database

2-s2.0-85101484558